These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 11099987
1. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Brown DW, Giles WH, Croft JB. Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987 [Abstract] [Full Text] [Related]
2. Hematocrit and the risk of coronary heart disease mortality. Brown DW, Giles WH, Croft JB. Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356 [Abstract] [Full Text] [Related]
3. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study. Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C. J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174 [Abstract] [Full Text] [Related]
4. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting. Toumpoulis IK, Chamogeorgakis TP, Angouras DC, Swistel DG, Anagnostopoulos CE, Rokkas CK. Int J Cardiol; 2009 Jun 12; 135(1):36-42. PubMed ID: 18579225 [Abstract] [Full Text] [Related]
5. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). Mensah GA, Brown DW, Croft JB, Greenlund KJ. Am J Prev Med; 2005 Dec 12; 29(5 Suppl 1):68-74. PubMed ID: 16389129 [Abstract] [Full Text] [Related]
6. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Pearte CA, Furberg CD, O'Meara ES, Psaty BM, Kuller L, Powe NR, Manolio T. Circulation; 2006 May 09; 113(18):2177-85. PubMed ID: 16651468 [Abstract] [Full Text] [Related]
7. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study. Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators. Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012 [Abstract] [Full Text] [Related]
8. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo L, Celentano A, Mininni N, de Divitiis O. Ital Heart J; 2001 Sep 28; 2(9):677-84. PubMed ID: 11666096 [Abstract] [Full Text] [Related]
9. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study]. Li Y, Zhao D, Liu J, Li CF, Guo W, Chen CH, Hao P, Sun JY, Qin LP, Wang W. Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov 28; 36(11):1037-42. PubMed ID: 19102921 [Abstract] [Full Text] [Related]
10. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease. Talmud PJ, Flavell DM, Alfakih K, Cooper JA, Balmforth AJ, Sivananthan M, Montgomery HE, Hall AS, Humphries SE. Clin Sci (Lond); 2007 Jun 28; 112(12):617-24. PubMed ID: 17291198 [Abstract] [Full Text] [Related]
11. Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients. Goodroe R, Bonnema DD, Lunsford S, Anderson P, Ryan-Baille B, Uber W, Ikonomidis J, Crumbley AJ, VanBakel A, Zile MR, Pereira N. J Heart Lung Transplant; 2007 Feb 28; 26(2):145-51. PubMed ID: 17258148 [Abstract] [Full Text] [Related]
12. Left ventricular hypertrophy and heart failure in women. Agabiti-Rosei E, Muiesan ML. J Hypertens Suppl; 2002 May 28; 20(2):S34-8. PubMed ID: 12183849 [Abstract] [Full Text] [Related]
13. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures. Greenberg J. Am J Hypertens; 2005 Aug 28; 18(8):1033-9. PubMed ID: 16109316 [Abstract] [Full Text] [Related]
14. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study]. Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J. Rev Esp Cardiol; 2006 Feb 28; 59(2):136-42. PubMed ID: 16540035 [Abstract] [Full Text] [Related]
15. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992. Fang J, Wylie-Rosett J, Alderman MH. Am J Hypertens; 2005 Jun 28; 18(6):751-8. PubMed ID: 15925731 [Abstract] [Full Text] [Related]
16. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Nephrol Dial Transplant; 2009 May 28; 24(5):1528-33. PubMed ID: 19073656 [Abstract] [Full Text] [Related]
17. Prognostic implications of left ventricular hypertrophy. Vakili BA, Okin PM, Devereux RB. Am Heart J; 2001 Mar 28; 141(3):334-41. PubMed ID: 11231428 [Abstract] [Full Text] [Related]
18. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB. J Hum Hypertens; 2007 Aug 28; 21(8):625-32. PubMed ID: 17476291 [Abstract] [Full Text] [Related]
19. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy. Kozakova M, Paterni M, Bartolomucci F, Morizzo C, Rossi G, Galetta F, Palombo C. Am J Hypertens; 2007 Mar 28; 20(3):279-84. PubMed ID: 17324740 [Abstract] [Full Text] [Related]
20. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study. Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB. J Hypertens; 2006 Oct 28; 24(10):2079-84. PubMed ID: 16957569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]